The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AAA/Endocyte/Novartis; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer; Sanofi
Consulting or Advisory Role - AAA/Endocyte/Novartis; AstraZeneca; Bristol-Meyers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen Oncology; MSD Oncology; Pfizer
Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.
 
Philippe Barthelemy
Honoraria - Astellas Pharma; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; SEAGEN
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Immunomedics; Janssen; Janssen (Inst); Loxo/Lilly; MSD Oncology; MSD Oncology (Inst); Pfizer/EMD Serono; Roche; Seagen; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Constance Thibault
No Relationships to Disclose
 
Marine Gross-Goupil
Consulting or Advisory Role - amgen; Amgen; Astellas Medivation; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Research Funding - Astrazeneca (Inst); Astrazeneca (Inst); BMS (Inst); ipsen (Inst); Janssen-Cilag (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; AstraZeneca; ipsen; ipsen; ipsen; Ipsen; Janssen-Cilag; MSD Oncology; MSD Oncology; pfizer; Pfizer; Roche
Other Relationship - Janssen
 
Jean Christophe Eymard
Consulting or Advisory Role - Astellas Pharma; IPSEN,; Janssen; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); IPSEN, (Inst); Pfizer (Inst)
 
Eric Voog
No Relationships to Disclose
 
Christine Abraham Jaillon
No Relationships to Disclose
 
Sylvestre Le Moulec
No Relationships to Disclose
 
Matthieu Chasseray
Honoraria - AstraZeneca; Merck KGaA
Consulting or Advisory Role - Merck KGaA
Travel, Accommodations, Expenses - Astellas Pharma; Daiichi Sankyo; IPSEN,; Lilly; Merck KGaA
 
Aurélien Gobert
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; IPSEN,; Janssen; Merck; Merck KGaA; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; IPSEN,; Janssen; Merck; Merck KGaA; Pfizer
Travel, Accommodations, Expenses - Merck KGaA; Pfizer; Sanofi
 
Benjamin Auberger
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; IPSEN,; Janssen; Merck; Merck KGaA; Pfizer; Sanofi
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; IPSEN,; Janssen; Merck; Merck KGaA; Pfizer
Travel, Accommodations, Expenses - Janssen; Merck KGaA; Pfizer; Sanofi
 
Caroline Viala
Consulting or Advisory Role - Advanced Accelerator Applications; Bristol-Myers Squibb; Merck; Merck KGaA
Travel, Accommodations, Expenses - Advanced Accelerator Applications; IPSEN,; Merck KGaA
 
Mathilde Cabart
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Eyad Kazan
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Gilead Sciences; IPSEN,; Janssen; Merck; Merck KGaA; Pfizer; Roche; Sanofi
 
Veronique Lorgis
No Relationships to Disclose
 
Werner Hilgers
Honoraria - Astellas Pharma; Bayer; Janssen; Pfizer
Travel, Accommodations, Expenses - Bayer; Novartis
 
Constant Josse
Employment - eXYSTAT
Research Funding - Merck KGaA (Inst); Pfizer
 
Prisca Lambert
Employment - Pfizer
 
Marie-Noelle Solbes
Employment - Merck KGaA
 
Aude Flechon
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; NOVARTIS; PFIZER; Roche/Genentech; Sanofi/Aventis
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis